metopimazine has been researched along with Basal Ganglia Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Galley, M; Heguy, J; Montastruc, JL; Plantavid, M; Seigneuric, C; Sorbette, F | 1 |
Angelo, HR; Hansen, M; Herrstedt, J; Kampmann, JP; Sigsgaard, T | 1 |
1 trial(s) available for metopimazine and Basal Ganglia Diseases
Article | Year |
---|---|
Dose-finding study of oral metopimazine.
Topics: Administration, Oral; Adult; Age Factors; Aged; Antiemetics; Antineoplastic Agents; Basal Ganglia Diseases; Blood Pressure; Dizziness; Dose-Response Relationship, Drug; Female; Forecasting; Headache; Humans; Hypotension, Orthostatic; Isonipecotic Acids; Male; Middle Aged; Sleep Stages; Xerostomia | 1997 |
1 other study(ies) available for metopimazine and Basal Ganglia Diseases
Article | Year |
---|---|
[Extrapyramidal syndrome. Possible role of metopimazine].
Topics: Basal Ganglia Diseases; Humans; Isonipecotic Acids; Male; Middle Aged | 1983 |